Buy & Sell GeneDx Holdings Corp (WGS) – GeneDx Holdings Corp Price Today
Key Stats
- $1.21BMarket Cap
- TechnologySector
- -63.49%3M Drawdown
- $1.21BEnterprise Value
- -Dividend Yield
- 24% Buy | 76% SellTrading Activity
- 5 daysTypical Hold Time
GeneDx Holdings Corp (WGS) is currently valued at a market capitalization of $1.21B, with an enterprise value of $1.21B. Over the past 52 weeks, GeneDx Holdings Corp has traded between a low of $34.51 and a high of $167.51, highlighting its annual price range. Over the past three months, GeneDx Holdings Corp has recorded a drawdown of -63.49%, reflecting recent price volatility. On average, investors hold GeneDx Holdings Corp for approximately 5 days, indicating typical investor behavior on the platform.
About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Most Recent News
Anthropic acquires Stainless to enhance developer tools and API connections for $300M.
Anthropic has acquired Stainless, a startup specializing in developer tools for APIs, for approximately $300 million. Stainless, founded in 2022, has worked with major clients including Google DeepMind, Meta, and OpenAI, and developed software linked...
Boston Scientific invests $1.5B for stake in MiRus, targeting advanced aortic stenosis treatment.
Boston Scientific has invested $1.5 billion to acquire about a 34% stake in MiRus, gaining exclusive rights to its investigational transcatheter aortic valve replacement (TAVR) system designed for severe aortic stenosis. The SIEGEL valve features a n...
Elliott sees hidden value in Bio-Rad via $5B Sartorius stake amid share price slump
Activist investor Elliott Investment Management has taken a significant stake in Bio-Rad Laboratories, which develops medical instruments and software. Bio-Rad's founding family retains majority voting control, complicating activist efforts. Elliott ...